Notice Pursuant to Section 708A(5)(e) of the Corporations Act

Imagion Biosystems has released "Notice Pursuant to Section 708A(5)(e) of the Corporations Act." Read the notice.


Appendix 3B

Imagion Biosystems has released Appendix 3B: New issue announcement, application for quotation of additional securities and agreement. Read Appendix 3B.


Change In Director's Interest Notice

Imagion Biosystems has released Change of Director's Interest Notices for David Ludvigson, Mark Van Asten, and Robert Proulx. Read the Change in Director's…


Form 604: Notice of change of interests of substantial holder

Imagion Biosystems Limited has released "Form 604: Notice of change of interests of substantial holder" to the market. Read Form 604.


Form 605: Notice of ceasing to be a substantial holder

Imagion Biosystems Limited has announced "Form 605: Notice of ceasing to be a substantial holder." Read Form 605.


Imagion Biosystems receives $300K order for supply of nanoparticles

Imagion Biosystems Limited announced the NewPhase Ltd., an Israeli biotechnology company developing cancer treatments, has placed an order totaling…


Completion of Renounceable Rights Issue

Imagion Biosystems has announced the successful completion of the renounceable rights issue raising approximately $3.6 million. Read Imagion Biosystems' Right…


Imagion Biosystems' Patent Issued in India

Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, has been issued patent #320872 from…


Offer Update and Appendix 3B

Imagion Biosystems Limited (ASX: IBX) (the Company) refers to its renounceable pro rata right issue offer of new fully paid ordinary shares (New Shares)…


Supplementary Prospectus

Imagion Biosystems Limited has announced a supplementary prospectus (Supplementary Prospectus) which shall be read with the prospectus dated 28 October 2019…